
CMLF P/E Ratio
P/E Ratio as of Feb 20, 2026: 1360.86
Average1554.26
Median1571.81
Minimum1360.86
Maximum1739.30
1360.86
431.51 (24.07%)past month
The P/E ratio for CMLF is 1360.86 as of Feb 20, 2026. This represents a decrease of -39.43% compared to its 12-month average P/E ratio of 2246.76. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
CM Life Sciences, Inc. P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
CM Life Sciences, Inc.’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing CM Life Sciences, Inc. to industry peers.
CM Life Sciences, Inc. P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
CM Life Sciences, Inc.’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing CM Life Sciences, Inc. to industry peers.
CMLF P/E Ratio Insights
See CM Life Sciences, Inc.’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in CMLF
Order type
Buy in
Order amount
Est. shares
0 shares
CMLF P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Dec 1, 2025 | $163.61 | 2713.27 |
| Nov 3, 2025 | $138.30 | 2293.53 |
| Oct 1, 2025 | $113.44 | 6066.31 |
| Sep 2, 2025 | $128.18 | 6854.55 |
| Aug 1, 2025 | $101.60 | 5433.16 |
| Jul 1, 2025 | $90.29 | -62.68 |
| Jun 2, 2025 | $74.13 | -51.46 |
| May 1, 2025 | $62.32 | -31.39 |
| Apr 1, 2025 | $84.59 | -42.61 |
| Mar 3, 2025 | $94.35 | -47.53 |
| Feb 3, 2025 | $69.98 | -22.07 |
| Jan 2, 2025 | $79.63 | -25.11 |
CMLF End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 1360.86 | -36.91% |
| 2025 | 2156.88 | -8,998.02% |
| 2024 | -24.24 | +30,200.00% |
| 2023 | -0.08 | -71.43% |
| 2022 | -0.28 | -94.67% |
| 2021 | -5.25 | — |
FAQs About CM Life Sciences, Inc. (CMLF) P/E ratio
The latest P/E ratio of CMLF is 1360.86, as of Feb 20, 2026. This is calculated based on its current stock price and earnings per share (EPS).
CM Life Sciences, Inc.’s last 12-month average P/E ratio is 2246.76, compared to its current P/E ratio of 1360.86. This reflects a decrease of -39.43%.
CM Life Sciences, Inc.’s current P/E ratio of 1360.86 is lower than its last 12-month average P/E of 2246.76. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
CM Life Sciences, Inc.’s average P/E ratio over the last 3 years is 745.05. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
CM Life Sciences, Inc.’s average P/E ratio over the last 5 years is 444.02. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.